Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...
查看详情The comparative study met its primary endpoints and showed equivalent efficacy and comparable safety profile in patients...
April 8th 2021, Biogen Inc. (Nasdaq: BIIB) and Bio-Thera Solutions, Ltd. (688177.SH) today announced that they entered i...
Bio-Thera Solutions (SHA: 688177), a commercial-stage biopharmaceuticalcompany, today announced that the U.S. Food and D...
